Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniel Arku
Observed names:
D Arku,
D. Arku
Institution:
University of Arizona
Observed institution:
University of Arizona
ORCID:
0000-0002-6185-5198
Observed ORCID:
0000-0002-6185-5198
OpenAlex ID:
A5079939053
Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis
2022
·
Srujitha Marupuru
, Daniel Arku
, et al.
·
Journal of Clinical Medicine
·
50
PDF
Program of All-Inclusive Care for the Elderly (PACE) versus Other Programs: A Scoping Review of Health Outcomes
2022
·
Daniel Arku
, Mariana Felix
, et al.
·
Geriatrics
·
43
PDF
Cost-effectiveness analysis of nivolumab-chemotherapy as first-line therapy for locally advanced/metastatic gastric cancer: a United States payer perspective
2023
·
Srujitha Marupuru
, Daniel Arku
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
14
PDF
Changing paradigms in detecting rare adverse drug reactions: from disproportionality analysis, old and new, to machine learning
2022
·
Daniel Arku
, Consuela Yousef
, et al.
·
Expert Opinion on Drug Safety
·
14
PDF
Comparing jurisdiction-specific pharmaco-economic evaluations using medical purchasing power parities
2021
·
Briana M. Choi
, Rachel B. Abraham
, et al.
·
Journal of Medical Economics
·
10
PDF
Pain Severity Is Associated with Self-Reported Functional Limitations: Findings from the 2018 Medical Expenditure Panel Survey (MEPS)
2022
·
Daniel Arku
, David R Axon
·
Pain Medicine
·
6
PDF
Evaluating the reliability and validity of a questionnaire used to measure experiences of teamwork among student pharmacists in a quality improvement course
2022
·
Daniel Arku
, Ziyad Almatruk
, et al.
·
Currents in Pharmacy Teaching and Learning
·
6
Assessing the Impact of an Advanced Clinical Decision Support System on Medication Safety and Hospital Readmissions in an Innovative Transitional Care Model: A Pilot Study
2022
·
Jennifer M. Bingham
, Lindsey Baugham
, et al.
·
Journal of Clinical Medicine
·
6
PDF
Associations of multiple (≥5) chronic conditions among a nationally representative sample of older United States adults with self-reported pain
2021
·
David R. Axon
, Daniel Arku
·
Scandinavian Journal of Pain
·
4
First-Line Systemic Therapy Outcomes in Western Population with Locally Advanced and Metastatic Gastric Cancer—A Systematic Review
2023
·
Srujitha Marupuru
, Daniel Arku
, et al.
·
Gastroenterology Insights
·
2
PDF
PCR237 Evaluating the Psychometric Properties of a Questionnaire Designed to Assess Headache Characteristics and Management Among United States Student Pharmacists
2023
·
U. Agu
, D. Arku
, et al.
·
Value in Health
EE154 Budget Impact Analysis of Pembrolizumab Plus Enfortumab Vedotin As First-Line Treatment of Cisplatin-Ineligible Locally Advanced or Metastatic Urothelial Carcinoma in USA
2023
·
Y. Lai
, H. Guo
, et al.
·
Value in Health
PDF
Exploring the Association of the COVID-19 Pandemic on Employee Sleep Quality at a Healthcare Technology and Services Organization
2022
·
Daniel Arku
, Jennifer M. Bingham
, et al.
·
COVID
PDF
POSC176 Is Pain Severity Associated with Functional Limitations Among United States Adults? A Cross-Sectional Study Using 2018 Medical Expenditure Panel Survey
2022
·
D Arku
, D Axon
·
Value in Health
POSA232 Evaluating Health Outcomes of Participants Enrolled in Program of All Inclusive Care for the Elderly (PACE) and Elderly Participants Enrolled in Other Care Giving Programs: A Scoping Review
2022
·
D Arku
, M Felix
, et al.
·
Value in Health
POSB305 Assessing the Reliability and Validity of an Instrument Used to Measure Student Pharmacists' Experiences of Teamwork in a Quality Improvement Course
2022
·
D Arku
, Z Almatruk
, et al.
·
Value in Health
Ixazomib (IXA), carfilzomib (CAR), elotuzumab (ELO) or daratumumab (DAR) with lenalidomide and dexamethasone (LEN+DEX) versus LEN+DEX only in relapsed/refractory multiple myeloma (R/R MM): A comparative cost-effectiveness analysis.
2021
·
Mavis Obeng-Kusi
, Daniel Arku
, et al.
·
Journal of Clinical Oncology
PSS17 Prevalence and Predictors of Multiple Chronic Conditions Among United States Older Adults with PAIN and Prescribed Opioids
2020
·
D. Axon
, D. Arku
, et al.
·
Value in Health
PSS15 Prevalence and Predictors of Multiple Comorbid Chronic Conditions Among a Nationally-Representative Sample of United States Older Adults with Self-Reported PAIN
2020
·
D. Axon
, H. Dhatt
, et al.
·
Value in Health
Show more works
View as search
Works count:
19
Citation count:
155
H-index:
6
I10-index:
5
Year
Topic
Type